# Astrazeneca Treasury (Astrazeneca Treasury Limited)

Private limited company registered in Cambridge, classed under “Activities of head offices”.

- Company number: 02910116
- Status: Active
- Type: Private limited company
- Incorporated: 18 March 1994
- Registered office: 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA
- Location: Cambridge
- Activity: Activities of head offices

## Latest filed profit

No profit figure in its latest filed accounts.

Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers.

## Questions people ask

### What does Astrazeneca Treasury do?

Private limited company registered in Cambridge, classed under “Activities of head offices”.

### How much turnover does Astrazeneca Treasury make?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/astrazeneca-treasury-02910116

### Is Astrazeneca Treasury profitable?

Astrazeneca Treasury's profit isn't public: small companies may file without a profit and loss account.

### Who runs and owns Astrazeneca Treasury?

Its directors are Camilla Johnstone, Matthew Shaun Bowden, Iain Alistair Collins, Jonathan Thomas Charles Slade. Its owners are shown to subscribers.

### Where is Astrazeneca Treasury based?

Its registered office is 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA, in Cambridge.

### When was Astrazeneca Treasury founded?

Astrazeneca Treasury Limited was incorporated on 18 March 1994.

### Is Astrazeneca Treasury still trading?

The register lists Astrazeneca Treasury Limited as active.

## Timeline

Recent filings and changes at Companies House.

- 2026-06-29: Full accounts made up to 31 December 2025
- 2025-07-03: Full accounts made up to 31 December 2024
- 2025-05-01: Appointment of Camilla Johnstone as a secretary on 1 May 2025
- 2025-05-01: Termination of appointment of Adrian Charles Noel Kemp as a director on 1 May 2025
- 2025-05-01: Termination of appointment of Matthew Shaun Bowden as a secretary on 1 May 2025
- 2025-04-23: Appointment of Matthew Shaun Bowden as a director on 22 April 2025
- 2024-09-13: Statement of capital following an allotment of shares on 2 August 2024 · GBP 100.00, USD 5,905,233,411.66 (and 1 more like it since 10 June 2023)
- 2024-08-05: Resolutions (and 6 more like it since 15 August 2005)
- 2024-07-01: Full accounts made up to 31 December 2023
- 2023-07-25: Full accounts made up to 31 December 2022
- 2023-03-17: Memorandum and Articles of Association
- 2023-03-14: Statement of capital on 14 March 2023 · GBP 100, USD 5,905,233,410.67
- 2023-03-14: Statement by Directors (and 7 more like it since 31 March 2006)
- 2023-03-14: Solvency Statement dated 14/03/23
- 2022-08-25: Full accounts made up to 31 December 2021
- 2021-09-08: Full accounts made up to 31 December 2020
- 2020-11-30: Full accounts made up to 31 December 2019
- 2019-09-19: Full accounts made up to 31 December 2018
- 2019-03-13: Appointment of Matthew Shaun Bowden as a secretary on 27 February 2019
- 2019-03-08: Termination of appointment of Katie Louise Jackson-Turner as a secretary on 27 February 2019
- 2018-10-04: Full accounts made up to 31 December 2017
- 2018-07-09: Appointment of Jonathan Thomas Charles Slade as a director on 20 June 2018
- 2018-01-08: Termination of appointment of Brendan James Boucher as a director on 31 December 2017
- 2017-12-18: Secretary's details changed for Katie Louise Jackson-Turner on 1 May 2016
- 2017-09-30: Full accounts made up to 31 December 2016

---

Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/astrazeneca-treasury-02910116